The Claim

In human skeletal muscle, aging is associated with increased mTORC1 activity, which suppresses autophagy and leads to the accumulation of damaged cellular components; rapamycin inhibits mTORC1 and may restore autophagic clearance.

Source: We Spent $724,637 Testing Rapamycin. What We Found Shocked Us.

What the research says

Not yet evaluated

We are still looking at what the research says.

Supports
0score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
0 studies reviewed
In plain English

As we get older, a protein in our muscles called mTORC1 can become overactive, which slows down the body's cleanup process for damaged parts inside cells. Taking rapamycin might help turn that cleanup process back on.

See the scientific wording

Aging is associated with mTORC1 hyperactivation in human skeletal muscle, which suppresses autophagy, leading to accumulation of damaged cellular components; rapamycin inhibits mTORC1, thereby potentially restoring autophagic clearance.

Score breakdown, mechanism chain, raw evidence, ideal studies needed

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.